The document discusses the importance of patient participation in medical research, noting that over 80% of people believe it is important for the NHS to offer research opportunities and that most trusts do not provide information to support patient choice in research. It emphasizes the need to increase patient willingness to participate in studies, enable greater choice, and involve patients in designing research from the beginning to help shape a system where research is a driver of higher quality care.
'Working Together in Research' - Leeds - 26th June 2013Simon Denegri
The document discusses public involvement in UK health research. It finds that most people support healthcare research and many would consider participating. However, few patients discuss research options with their doctors or receive information about available studies. The National Institute for Health Research aims to improve public participation through several initiatives. These include supporting relevant research, open data sharing, and empowering patients to help guide research priorities and experiences. The goal is to develop partnerships between researchers and the public to improve research quality and patient outcomes.
Leicester CLRN Meeting 'Making it real' 19 June 2013Simon Denegri
This document discusses public involvement in UK health research. It notes that public involvement is a core principle of the National Institute for Health Research and has been shown to improve research quality. The NIHR provides funding to support public involvement through all stages of research from setting priorities to design and delivery. There has been growth in policies that support patient choice and participation in research. However, challenges remain in fully enabling patient choice in research and ensuring high quality experiences for all patients. The document advocates for continued collaborative efforts between the public, researchers, and others to further promote patient-centered research in the NHS.
Presentation by Simon Denegri (NIHR) and Jennifer Preston (MCRN) to the Nuffi...Simon Denegri
The document discusses public involvement in health research and young people. It notes that the National Institute for Health Research (NIHR) sees public involvement as a core principle and has invested millions to support involvement. It provides a working definition of involvement as research being carried out "with" or "by" the public rather than "to", "about", or "for" them. The document also highlights the value involvement can add to ensuring research questions are relevant and outcomes are accessible and useful. It cites examples of involvement contributing to priority setting, study design and delivery, and review of research.
Cihr guest presentation and webinar afternoon talk - january 2014Simon Denegri
Presentation on public involvement and engagement in health research: why, how and what next? Given to the staff of the Canadian Institutes for Health Research (CIHR), Ottawa, Canada, 2014
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)NHSNWRD
"Let's talk patients and the public in research": Simon Denegri's talk looked at the key roles of patients, carers and the public in making research of public benefit happen.
Let's talk people in research sept 2014Simon Denegri
This slide-deck covers the main components of current NIHR approaches towards public involvement in research; its ongoing strategic review of the area and; its current policy towards engaging patients through the NHS.
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Nowgen
Involving People: Patients, Participants & Consumers in U.K.Cancer Research, presented by Richard Stephens at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Simon Denegri - Public involvement in CLAHRCsCLAHRC-NDL
Simon Denegri (INVOLVE chair and NIHR National Director for Public Participation and Engagement in Research) keynote presentation at NIHR CLAHRC East Midlands launch event on 14 February 2014, Loughborough.
'Working Together in Research' - Leeds - 26th June 2013Simon Denegri
The document discusses public involvement in UK health research. It finds that most people support healthcare research and many would consider participating. However, few patients discuss research options with their doctors or receive information about available studies. The National Institute for Health Research aims to improve public participation through several initiatives. These include supporting relevant research, open data sharing, and empowering patients to help guide research priorities and experiences. The goal is to develop partnerships between researchers and the public to improve research quality and patient outcomes.
Leicester CLRN Meeting 'Making it real' 19 June 2013Simon Denegri
This document discusses public involvement in UK health research. It notes that public involvement is a core principle of the National Institute for Health Research and has been shown to improve research quality. The NIHR provides funding to support public involvement through all stages of research from setting priorities to design and delivery. There has been growth in policies that support patient choice and participation in research. However, challenges remain in fully enabling patient choice in research and ensuring high quality experiences for all patients. The document advocates for continued collaborative efforts between the public, researchers, and others to further promote patient-centered research in the NHS.
Presentation by Simon Denegri (NIHR) and Jennifer Preston (MCRN) to the Nuffi...Simon Denegri
The document discusses public involvement in health research and young people. It notes that the National Institute for Health Research (NIHR) sees public involvement as a core principle and has invested millions to support involvement. It provides a working definition of involvement as research being carried out "with" or "by" the public rather than "to", "about", or "for" them. The document also highlights the value involvement can add to ensuring research questions are relevant and outcomes are accessible and useful. It cites examples of involvement contributing to priority setting, study design and delivery, and review of research.
Cihr guest presentation and webinar afternoon talk - january 2014Simon Denegri
Presentation on public involvement and engagement in health research: why, how and what next? Given to the staff of the Canadian Institutes for Health Research (CIHR), Ottawa, Canada, 2014
Let's Talk Research Annual Conference - 24th-25th September 2014 (Simon Denegri)NHSNWRD
"Let's talk patients and the public in research": Simon Denegri's talk looked at the key roles of patients, carers and the public in making research of public benefit happen.
Let's talk people in research sept 2014Simon Denegri
This slide-deck covers the main components of current NIHR approaches towards public involvement in research; its ongoing strategic review of the area and; its current policy towards engaging patients through the NHS.
Involving People: Patients, Participants & Consumers in U.K.Cancer Research (...Nowgen
Involving People: Patients, Participants & Consumers in U.K.Cancer Research, presented by Richard Stephens at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Simon Denegri - Public involvement in CLAHRCsCLAHRC-NDL
Simon Denegri (INVOLVE chair and NIHR National Director for Public Participation and Engagement in Research) keynote presentation at NIHR CLAHRC East Midlands launch event on 14 February 2014, Loughborough.
Patient involvement in medicines development – the views of patients and key ...Nowgen
"EUPATI – EU: An overview", held by Bella Starling & Suzanne Parsons (EUPATI / Nowgen) at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)Nowgen
"INVOLVE perspectives on learning and development", presented by Sarah Buckland, INVOLVE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Professor Kamlesh Khunti - Prevention of Chronic DiseaseCLAHRC-NDL
Presentation by Professor Kamlesh Khunti on Prevention of Chronic Disease. Professor Khunti is Director of NIHR CLAHRC East Midlands and leads the Preventing Chronic Disease research theme.
Bringing the patient voice into GSK for educational, awareness and patient ce...Nowgen
"Bringing the patient voice into GlaxoSmithKline for educational, awareness and patient centred decisions within medicine development", presented by Kay Warner, Global Manager, Focus on the Patient, GlaxoSmithKline, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Professor Richard Morriss - Enhancing Mental HealthCLAHRC-NDL
Presentation on Enhancing Mental Health theme research, by Professor Richard Morriss at the NIHR CLAHRC East Midlands launch event, 14 February 2014, Loughborough.
Patients at the Centre for Health Research – Patient, Carer and Public Invol...Nowgen
"Patients at the Centre for Health Research –
Patient, Carer and Public Involvement in NICE Decision-Making", presented by Victoria Thomas, NICE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Co-design, Co-produce, Co-deliver: Collaboration is the only viable path to s...Simon R. Stones
In this presentation, delivered to the Translate external advisory board at their bi-annual meeting, the importance of patient and public involvement in research is highlighted, as well as simple strategies that researchers, healthcare professionals and private organisations can take to involve people in all aspects of research, from the bench to the bedside.
CER 2016 Jacoby stakeholder engagementCTSI at UCSF
This document discusses stakeholder engagement in patient-centered outcomes research. It begins by explaining the change from a researcher-centered model to including stakeholders. Key stakeholders are identified as patients, providers, drug/device companies, insurers, and advocates. Stakeholder engagement is required by PCORI to support funding, improve enrollment, strengthen research design, and broaden impact. Examples are provided of how a study on uterine fibroid treatment engaged stakeholders in design, recruitment, and dissemination of results. Challenges and new approaches like crowdsourcing input are also discussed.
Member experiences in an Australian Translational Cancer Research Centre and ...Cancer Institute NSW
The experience of membership of multidisciplinary collaborative cancer research networks is largely unreported. Sydney Catalyst Translational Cancer Research Centre (TCRC) is a multi-disciplinary and multi-institutional virtual consortium of researchers and clinicians from institutions in metropolitan Sydney and regional New South Wales. Following the Westfall model of translational research, we support multi-disciplinary collaborative cancer research focused on T1112 bench to bedside research and T2/3 translation of evidence into practice.
Patient involvement in clinical research and long term conditions -what can b...Nowgen
"Patient involvement in clinical research and long term conditions -what can be achieved by working in partnership", presented by Dr. J. Paul Schofield, ABPI, at EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Ensuring research really does involve the young personSimon R. Stones
This presentation was delivered during a session discussing the ethics of conducting research with children and young people. The presentation emphasises the importance of involving children, young people and their families in the design and conduct of research, in order to make it more relevant.
This document discusses a project called EQUIP that aims to develop new methods for analyzing and displaying qualitative data in patient-centered outcomes research (PCOR). The project will draw on existing studies involving over 200 cancer patients to develop tools for extracting narratives from illness experiences. An "ethnoarray" approach is proposed to visually array patients' narratives based on domains like treatment decisions and social support. The goals are to engage stakeholders like researchers, providers, and patients to establish standards for using qualitative data in PCOR and assess new methods' feasibility in clinical practice. Challenges include bridging different disciplinary approaches, but the project sees opportunities to innovate at the intersection of qualitative and quantitative health research methods.
The document discusses the Prime Minister's Challenge on Dementia and progress that has been made. It notes that £22 million has been invested in 21 new dementia research studies. It also discusses how the DeNDRoN (Dementia and Neurodegenerative Diseases Research Network) is supporting this research through providing infrastructure and practical support to researchers. DeNDRoN is working to increase participation in clinical trials and dementia research studies.
The document discusses new initiatives at the Patient-Centered Outcomes Research Institute (PCORI) related to pragmatic clinical studies and engagement. Key points include:
- PCORI is emphasizing large pragmatic clinical studies to compare medical interventions and engage patients and other stakeholders throughout the research process.
- New areas of focus include establishing study advisory committees involving stakeholders, engaging medical societies in research, and funding the dissemination of study results.
- PCORI is prioritizing research topics nominated by patients and other stakeholders and conducting targeted funding opportunities on focused clinical questions.
Flash Allocation d'Actifs : le « Bull Market » est challengé sur ses 3 pilier...OFI Asset Management
Depuis 4 ans, les marchés sont portés par un environnement favorable qui repose sur trois « piliers » : une croissance mondiale suffisamment solide pour l’expansion des entreprises mais qui n’engendre pas de pressions inflationnistes, ce qui permet le maintien de taux d’intérêt assez bas et induit des politiques monétaires
lisibles… Ce cercle positif est « challengé » ces dernières semaines…
This document provides an overview of the process for making a mural. It begins with selecting a suitable location with a surface that can be painted on. The designer then chooses a design that the community will enjoy, often using a grid method to translate the design onto the mural site. Acrylic paint is commonly used since it dries quickly without fading or smearing. The painting process involves applying an undercoat layer, followed by layers of colored paints. A final glossy paint layer is applied to give the mural a clean, bright finish and attract attention from the community. The document emphasizes that creating a mural requires significant effort from design to completion.
Patient involvement in medicines development – the views of patients and key ...Nowgen
"EUPATI – EU: An overview", held by Bella Starling & Suzanne Parsons (EUPATI / Nowgen) at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
INVOLVE perspectives on learning and development (Sarah Buckland, INVOLVE)Nowgen
"INVOLVE perspectives on learning and development", presented by Sarah Buckland, INVOLVE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Professor Kamlesh Khunti - Prevention of Chronic DiseaseCLAHRC-NDL
Presentation by Professor Kamlesh Khunti on Prevention of Chronic Disease. Professor Khunti is Director of NIHR CLAHRC East Midlands and leads the Preventing Chronic Disease research theme.
Bringing the patient voice into GSK for educational, awareness and patient ce...Nowgen
"Bringing the patient voice into GlaxoSmithKline for educational, awareness and patient centred decisions within medicine development", presented by Kay Warner, Global Manager, Focus on the Patient, GlaxoSmithKline, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
Professor Richard Morriss - Enhancing Mental HealthCLAHRC-NDL
Presentation on Enhancing Mental Health theme research, by Professor Richard Morriss at the NIHR CLAHRC East Midlands launch event, 14 February 2014, Loughborough.
Patients at the Centre for Health Research – Patient, Carer and Public Invol...Nowgen
"Patients at the Centre for Health Research –
Patient, Carer and Public Involvement in NICE Decision-Making", presented by Victoria Thomas, NICE, at the EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Co-design, Co-produce, Co-deliver: Collaboration is the only viable path to s...Simon R. Stones
In this presentation, delivered to the Translate external advisory board at their bi-annual meeting, the importance of patient and public involvement in research is highlighted, as well as simple strategies that researchers, healthcare professionals and private organisations can take to involve people in all aspects of research, from the bench to the bedside.
CER 2016 Jacoby stakeholder engagementCTSI at UCSF
This document discusses stakeholder engagement in patient-centered outcomes research. It begins by explaining the change from a researcher-centered model to including stakeholders. Key stakeholders are identified as patients, providers, drug/device companies, insurers, and advocates. Stakeholder engagement is required by PCORI to support funding, improve enrollment, strengthen research design, and broaden impact. Examples are provided of how a study on uterine fibroid treatment engaged stakeholders in design, recruitment, and dissemination of results. Challenges and new approaches like crowdsourcing input are also discussed.
Member experiences in an Australian Translational Cancer Research Centre and ...Cancer Institute NSW
The experience of membership of multidisciplinary collaborative cancer research networks is largely unreported. Sydney Catalyst Translational Cancer Research Centre (TCRC) is a multi-disciplinary and multi-institutional virtual consortium of researchers and clinicians from institutions in metropolitan Sydney and regional New South Wales. Following the Westfall model of translational research, we support multi-disciplinary collaborative cancer research focused on T1112 bench to bedside research and T2/3 translation of evidence into practice.
Patient involvement in clinical research and long term conditions -what can b...Nowgen
"Patient involvement in clinical research and long term conditions -what can be achieved by working in partnership", presented by Dr. J. Paul Schofield, ABPI, at EUPATI-UK Network Conference on 6 March 2014 in Leeds, UK
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Ensuring research really does involve the young personSimon R. Stones
This presentation was delivered during a session discussing the ethics of conducting research with children and young people. The presentation emphasises the importance of involving children, young people and their families in the design and conduct of research, in order to make it more relevant.
This document discusses a project called EQUIP that aims to develop new methods for analyzing and displaying qualitative data in patient-centered outcomes research (PCOR). The project will draw on existing studies involving over 200 cancer patients to develop tools for extracting narratives from illness experiences. An "ethnoarray" approach is proposed to visually array patients' narratives based on domains like treatment decisions and social support. The goals are to engage stakeholders like researchers, providers, and patients to establish standards for using qualitative data in PCOR and assess new methods' feasibility in clinical practice. Challenges include bridging different disciplinary approaches, but the project sees opportunities to innovate at the intersection of qualitative and quantitative health research methods.
The document discusses the Prime Minister's Challenge on Dementia and progress that has been made. It notes that £22 million has been invested in 21 new dementia research studies. It also discusses how the DeNDRoN (Dementia and Neurodegenerative Diseases Research Network) is supporting this research through providing infrastructure and practical support to researchers. DeNDRoN is working to increase participation in clinical trials and dementia research studies.
The document discusses new initiatives at the Patient-Centered Outcomes Research Institute (PCORI) related to pragmatic clinical studies and engagement. Key points include:
- PCORI is emphasizing large pragmatic clinical studies to compare medical interventions and engage patients and other stakeholders throughout the research process.
- New areas of focus include establishing study advisory committees involving stakeholders, engaging medical societies in research, and funding the dissemination of study results.
- PCORI is prioritizing research topics nominated by patients and other stakeholders and conducting targeted funding opportunities on focused clinical questions.
Flash Allocation d'Actifs : le « Bull Market » est challengé sur ses 3 pilier...OFI Asset Management
Depuis 4 ans, les marchés sont portés par un environnement favorable qui repose sur trois « piliers » : une croissance mondiale suffisamment solide pour l’expansion des entreprises mais qui n’engendre pas de pressions inflationnistes, ce qui permet le maintien de taux d’intérêt assez bas et induit des politiques monétaires
lisibles… Ce cercle positif est « challengé » ces dernières semaines…
This document provides an overview of the process for making a mural. It begins with selecting a suitable location with a surface that can be painted on. The designer then chooses a design that the community will enjoy, often using a grid method to translate the design onto the mural site. Acrylic paint is commonly used since it dries quickly without fading or smearing. The painting process involves applying an undercoat layer, followed by layers of colored paints. A final glossy paint layer is applied to give the mural a clean, bright finish and attract attention from the community. The document emphasizes that creating a mural requires significant effort from design to completion.
El documento define varios términos pedagógicos y educativos, incluyendo utopía, pormenorización, parricidio, abdicación, monopolio, epifenómeno, hegemonía, matriz, escuela, pedagogía, didáctica, alianza, maestro, adaptación y contrato. Cada definición incluye el término, su significado y el autor de la definición.
Istanbul IETT Professional Development Workshop, #4 of 6_Transit & Land UseVTPI
Istanbul IETT Professional Development Workshop, #4 of 6, Transit & Land Use
Presenter: Todd Litman, Victoria Transport Policy Institute
Assistant: Aysha Cohen, UCLA Institute of Transportation Studies Scholar
Presentation Date: June 15, 2015
O documento fornece orientações sobre como elaborar um currículo eficaz, incluindo: 1) focar-se nos pontos fortes e justificar interrupções; 2) usar frases curtas e claras; 3) pedir feedback antes de enviar. Também discute como preencher o modelo Europass de forma lógica e inverter a ordem das seções, quando necessário.
This certificate certifies that Sivaram Appali has demonstrated the requirements to be an Oracle SOA Suite 11g Sales Specialist as of November 3, 2011.
This certificate certifies that Sivaram Appali has demonstrated the requirements to be an Oracle Service Oriented Architecture Infrastructure Implementation Certified Expert as of November 14, 2011.
Este documento define conceptos básicos como signo, estímulo, conjunto, código, señal, forma, símbolo y percepción. Explica que un signo transmite contenidos representativos, un estímulo provoca una reacción, un conjunto es una agrupación de elementos, un código representa información mediante símbolos, una señal informa o avisa, la forma da información sobre el aspecto de las cosas, un símbolo representa una idea mediante convención social y la percepción obedece a estímulos cerebrales a través de
1) A AnimaR promove a criação de emprego e autoempleo na área da Economia Social e Solidária, contribuindo para o desenvolvimento das comunidades locais.
2) O documento descreve a estratégia da AnimaR para fomentar o empreendedorismo na região através da distinção de serviços técnicos nas fases do desenvolvimento empresarial.
3) A AnimaR assinou um Acordo de Cooperação com o INSTITUTO DE EMPRESAS E FORMACIÓN PROFESIONAL para promover novas inic
This certificate certifies that Sivaram Appali has demonstrated the requirements to be an Oracle SOA Suite 11g PreSales Specialist as of November 3, 2011.
This talk was given to the Alberta Cancer Foundation in Calgary, January 2015. It looks at different approaches to public involvement in research funding by UK charities. It also includes some updated slides on the results of the Breaking Boundaries review.
The value off engaging patients in researchSimon Denegri
This is a talk I gave at the Council of Academic Hospitals of Ontario (CAHO) 'Healthier Wealthier, Smarter' conference in Toronto on 1st June 2015. Do visit their new website: http://caho-hospitals.com/
Isn't this about me? The role of patients and the public in implementing evid...NEQOS
Master Class, led by Professor Richard Thomson- focusing on the role of patients and public in implementing evidence-based healthcare- including shared decision making
This document summarizes the results of a survey conducted by IPPOSI on patient data. It shows that 103 responses were received from IPPOSI members and non-members. The survey asked questions to understand respondents' familiarity with and views on electronic health records, data sharing, and key topics. It also identified the most interesting topics to members as improving data quality and infrastructure, addressing trustworthiness, and probing data privacy and protection. Additional topics suggested for focus included patient representation, integrated care, and data access. The document provides insights into stakeholders' priorities and concerns around patient data issues.
Anne Webster, -Clinical Lead Winterbourne Projects, NHS England,
Joanne McDonnell - Senior Nurse for Mental Health and Learning Disabilities, NHS England
Neil Hoskin - Expert by Experience, NHS England
Presentation from the Winterbourne Medicines Programme Launch held in London on 10 September 2014
Ensuring safe, appropriate and optimised use of medication for people with learning disabilities who demonstrate behaviour that can challenge
Presentation to National Institute for Health Research (NIHR) Public Involvem...Simon Denegri
This presentation includes slides detailing the initial findings from the NIHR Strategic Review of public involvement in research entitled 'Breaking Boundaries.'
Cure care and research in English dementia policyshibley
I set out to make current dementia policy in England open to the public. This is the final talk to be given by me, Dr Shibley Rahman, at BPP Law School this evening, on cure, care and research.
Patient, carer & public involvement in clinical guidelines: the NICE experienceGuíaSalud
Presentación de Victoria Thomas, Associate Director, Patient & Public Involvement Programme de NICE, sobre la participación de pacientes, ciudadanos y público en general en el desarrollo de guías de práctica clínica del NICE. Ponencia realizada en la Jornada Científica GuíaSalud 2010 "La participación de los pacientes en las Guías de Práctica Clínica".
Would knowing your genetic risk for dementia change the way you behave with t...shibley
This document summarizes an online survey that examined whether knowledge of genetic risk for dementia would change how people in the UK interact with the National Health Service. The survey used a sample of 125 respondents recruited from Twitter and found that knowledge of genetic risk may not drive people to behave like traditional private insurance markets. The discussion notes the sample was limited and a larger study is needed, but results suggest people prioritize their own health over financial risk and appreciate environmental factors in dementia.
Digital technologies like wireless sensors, genomics, EHRs, mobile apps, and big data analytics can significantly help patients but cannot replace human compassion and advocacy. These technologies can improve patient engagement, access to information, and personalized care. However, the most effective patient advocates will still be human beings who can combine technology tools with qualities like empathy, communication skills, and devotion of time to help patients navigate the healthcare system.
This document summarizes a presentation about the Patient Centered Outcomes Research Institute (PCORI) and its methods. It discusses how PCORI funds research to help patients make informed healthcare decisions by producing high-quality evidence. Key points include that PCORI research must be patient-centered, compare at least two alternatives, and use outcomes that matter to patients. It also outlines PCORI's research portfolio, methodology standards, and application review process.
This presentation was delivered as part of a seminar to the Child Health Evaluative Sciences (CHES) Research Group, based at The Hospital for Sick Children (SickKids) in Toronto, ON, Canada. The presentation focused on the importance and some of the practicalities of involving young people in research.
APA 2015_LM Brady involving cyp in research_03.15Louca-Mai Brady
This document discusses children and young people's involvement in research. It defines key terms like consultation, participation, and involvement. It explores models of involvement from being research subjects to collaborators. Practical and ethical considerations for involving children and young people are discussed. Examples of children's advisory groups for health research are provided. The document challenges myths about young people's ability to be involved and provides tips for planning their involvement.
Factors that Influence Adherence to HAART - Naicker MHmichaela naicker
The document summarizes factors that influence adherence to highly active antiretroviral therapy (HAART) based on interviews with 13 HIV-positive individuals in South Africa. Key factors identified include: social support from family and friends which positively influences adherence; socioeconomic challenges like poverty, transportation costs, and unemployment which negatively impact adherence; and healthcare provider factors where public clinics raised privacy concerns but private providers offered more support and counseling. Disease symptoms and stigma also influence individual medication adherence. Overall, the study found social, economic, healthcare, personal, and treatment-related factors all play a role in levels of adherence.
Slides of the Talk Fabian Zimmer & I gave on the SIGINT 12 in Cologne. A video of the talk can be found here:
http://ftp.ccc.de/events/sigint12/mp4/vortrag_mp6_og_-_2012-05-19_20_00_-_power_to_the_patient_-_bastian_greshake_-_fabian_zimmer_-_40.mp4
One London conversation workshop 18 July slide deck Katie Harrison
This document provides background information on the One London Local Health and Care Record Programme. It discusses how currently in the NHS and social care systems, there is no single shared record of a person's care across organizations. This can lead to fragmented and reactive care. The One London proposal aims to address this by creating a local health and care record that is shared across London. It would contain a person's medical history, test results, diagnoses, procedures, appointments, prescriptions, care plans and more. This would allow care teams to access all relevant information about a person. It would also enable more proactive management of populations and empower people to access and contribute to their own records. The document outlines how a One London record could transform
Human Genomics and Public Health in a Global World: Challenges for Low & Midd...Human Variome Project
This document discusses challenges for low and middle income countries regarding human genomics and public health in a global context. It notes that while genomics activity is increasing in about 50 countries, it remains fragmented without systematic monitoring or links to health policymakers. Five priorities for international genomics are identified: building an evidence base for genomic medicine, addressing health disparities, managing diverse patient populations, implications for medical education, and coordination across diseases. The document argues for greater global collaboration to improve access, establish standards, and promote equity and justice.
1. Dementias & Neurodegenerative
Diseases Research Network
“Is there a patient in the house?
- public involvement in research”
Simon Denegri
NIHR National Director for Public Participation and Engagement in Research
2. Patient participation in NHS
research
Public appetite
• 82 % of people believe it is important
for the NHS to offer opportunities to
take part in healthcare research.
NIHR Clinical Research Networks Survey May 2012
• 81% are willing to get involved in
dementia research
• 76% of people believe experiences
of patients and carers could be
important for shaping research
studies.
YouGov for Alzheimer's Research UK 2013
Patient experience
• 91% of Trusts do not provide
information to support patient
choice in research
NIHR CRN CC Mystery Shopper 2013
• 34% of respondents did not know
enough about what participating
in research would involve - and
this % is slightly higher amongst
older age groups
• Very few people appear to know
someone who has taken part in
research
YouGov for Alzheimer's Research UK 2013
3. Dementias & Neurodegenerative
Diseases Research Network
Policy, legislative and
organisational framework
• Life Sciences Strategy
• Health and Social Care Act 2012
• NHS Choice Framework
• NHS Constitution; use of medical records in research
• Organisations: CCGs, Healthwatch, DeNDRoN, Academic
Health Science Networks (AHSNs)
“Patient experience is the most important concern for the
NHS Commissioning Board”
Sir Malcolm Grant , Chair, NHSCB
4. Dementias & Neurodegenerative
Diseases Research Network
Reasoning for taking part –
THE EVIDENCE
• Can improve quality of life / treatment
• Altruistic motives
• Interaction between study coordinators and
patient/carers
5. Dementias & Neurodegenerative
Diseases Research Network
How can you can get involved?
• Taking part by participating in
a clinical research study
• Becoming a member of a
patient research group to
share your views on our
research ideas.
6. Dementias & Neurodegenerative
Diseases Research Network
“We want more people into clinical trials;
more people getting that chance to get the
very latest drugs. Our ambition is this: at
least 10 per cent of people with dementia
should be able to take part in clinical trials
– up around ten times from today”
March 26 2012: Prime Minister’s Challenge on Dementia: Delivering
major improvements in dementia care and research by 2015
“
“
7. 665,065
People estimated to
be living with
dementia in
England
4% Of people with
dementia were involved
in a dementia-related
study in 2012
The challenge
8. Dementias & Neurodegenerative
Diseases Research Network
Challenge areas
• Increasing willingness
• Enabling patient choice
• Involving patients from the beginning
• Seeing research as a key driver of quality
• Putting a human face on data to inform choice and
improve health
9. “Every patient who
walks through our
hospital doors is offered
the chance to take part
in a clinical trial”
I was able to
refer myself to a
clinical trial unit
They told myself
and other
patients what
they found out in
the trial before
anyone else.
It was easy for
me to find out
what’s going
on locally
I was able to
discuss taking
part in research
with my doctor
shortly after I
was diagnosed
I feel as though I
was able to make a
difference
Patients can talk
to other patients
in our Trust to
find out more
about research
My care and
treatment was
of a higher
quality
I joined the
national register
for research
First I took
part and now I
help design
trials. How
good is that?
10. Dementias & Neurodegenerative
Diseases Research Network
Patient-driven access
• Vision will be achieved by patients and the
public:
– Asking about research
– Choosing to take part in research
– Knowing their contribution has made a difference
– Shaping the way in which research is designed and
delivered
– Leading change at local and national level to make
research happen
– Reporting on and sharing their experiences with
commissioners and providers
14. Dementias & Neurodegenerative
Diseases Research Network
Patients in Research infokit
A platform to share stories, ideas,
tips and tools to embed research
across the NHS.
www.patientsinresearch.org
EXPLORE
CREATE
TELL US
how others are integrating
research into care
your own strategy to embed
research
about your initiative no
matter what your disease
area
15. What can you do?
Get research on the
agenda
2
Support “It’s OK to ask”
campaign
1
Sign up to DeNDRoN
community
3
16. Dementias & Neurodegenerative
Diseases Research Network
Want to know more?
Visit: www.dendron.nihr.ac.uk
Email: info@dendron.org.uk
Phone: 020 3206 4960
Editor's Notes
Presentation will coverWhat is your right?What you can do as a patient to get involved in clinical research? How this will help shape the future of dementia?
Improve quality of life / treat disease The most important reason given by carers was direct medical benefit to the patient, help the relative feel better and even to cure their ADIn one survey, several caregivers stated that a sense of desperation they felt about finding help for their relative motivated their enrolment, but this feeling of desperation was low on the list of reasons(Mastwyk, Ritchie et al. 2002; Mastwyk, Macfarlane et al. 2003) (Lynoe, Sandlund et al. 1991; Karlawish, Casarett et al. 2001)Altruistic motivesbelief that participation benefits others in future cited by one participant was that they cannot leave money to the university but can help by contributing to research (Lynoe, Sandlund et al. 1991; Morrow, Hickok et al. 1994; Connell, Shaw et al. 2001; Mastwyk, Ritchie et al. 2002; Mastwyk, Macfarlane et al. 2003)Interaction between study coordinators and patient/carersTrust in doctor and their medical knowledge is another common reason for one to participate in clinical studies in general (Geston and Mcvamara 1984)Some participants report that enrolling in a clinical study gets the patient more medical attention and that the medical system takes better care of you when you participate (Connell and Gallant 1996)Although there was no change physically or emotionally to the patient as a result of participating, majority of carers felt that participation was a positive experience
Patients are at the centre of what we do. As a patient, carer or a member of the public you can help research.By being involved in a ‘research patient group’ your help will ensure we continue to deliver exceptional healthcare now and in the future.You don't need any research experience. People with personal experience of healthcare are best placed to comment on what research is needed and how research should be done.Members of the public can bring a different perspective that is not always the same as those of researchers. Your involvement helps to ensure that the process is focused on what is important to people making it more relevant and acceptable to people who need to use our services.For example……being part of a research patient panel you will be able to:Comment on researchers’ treatment ideasComment on how treatment will be carried outRead and give feedback on patient information sheets, letters to patients and questionnairesParticipate in Research Committees and Research Project Meetings
2 key pointsPM challenge – This is a Government priority10% ambitionPatient and public involvement throughout
Currently only 4% of patients are involved in research, but we are aiming for 10%, so there is a lot more work yet that needs to be done….This is where you (audience) come in…… we need every trust to get research on the agenda, we every patient and carer asking their clinician or nurse, every health profession asking their patients, and signing up to research.
Patient pull-through increasing willingness to take part in clinical researchEnabling patient choice in research as part of the care pathwayResponding to the patient challenge over how research is conducted and their part in itEncouraging NHS leadership and culture to see research as a key driver of qualityInformation-sharing, transparency and openness: putting a human face on data to inform choice and improve health
Collaborative working to:Supporting patient choiceDefining and diffusing models of public involvement that drive participationImproving public awareness and understandingLearning from patient insight and experience Supporting patient and organisational leadership
Key messagesWhat we want people to doHow they can help
Initiatives like Patients in Research are trying to get research on the agenda of every organisation:Research should be a core part of any care pathway.The infokit is a platform to share ideas and practice: showcase work from across the NHS and research community to improve patient participation in research and recruitment to studies.All NHS organisations should be offering research. And there are many ways they can achieve this – some of the universal themes, irrespective of the field. changing culturepartnering with othersintegrating research into care pathwaysExplore the website and tell us how you are doing itAn example of a project to empower patients to askDescription: When it comes to recruiting people into clinical trials and studies, the onus is often placed squarely with the consultant to ask their patients about involvement in research. However, in an environment where the consultation period is short, research can often slip off the agenda. The Dementias and Neurodegenerative Diseases Research Network (DeNDRoN) decided to look at this issue from another angle by asking whether the patient could easily be empowered to take the responsibility for asking their consultant about getting involved rather than the other way around. To do this, the network worked closely with a number of managers and service leads across their host Trust to investigate the possibility of placing a simple sentence about research involvement at the bottom of every outpatient appointment letter.Impact: The results, although impressive, were not due to patient empowerment as expected. But once again proved the importance of engaging patient facing NHS staff in research and the positive impact one small simple change can make to patient recruitment. Through altering the trust approval process and standard appointment letters, consultants were more aware of the research going on locally and referred more patients to research.
A role and responsibility everyone to promote and integrate research. Talk about researchHave a conversation about research and whether they might be interested in being involved in future research.Use the UK Clinical Trials Gateway website to find out about research that might be relevant to your patients.2. Get research on the organisational agendaResearch needs to be embedded at all levels of the organisation – from the board to the ward. We need to make it a routine part of care.3. Get more involvedSign up to the Research Ready Care Home Network – see DeNDRoN websiteJoin the DeNDRoN community.Patients and carers – register your interest in being involved in research – on DeNDRoN website.